SI1608400T1 - Elevation of adenosine level by cytokine-induced expression of cd73 - Google Patents

Elevation of adenosine level by cytokine-induced expression of cd73

Info

Publication number
SI1608400T1
SI1608400T1 SI200431498T SI200431498T SI1608400T1 SI 1608400 T1 SI1608400 T1 SI 1608400T1 SI 200431498 T SI200431498 T SI 200431498T SI 200431498 T SI200431498 T SI 200431498T SI 1608400 T1 SI1608400 T1 SI 1608400T1
Authority
SI
Slovenia
Prior art keywords
cytokine
elevation
induced expression
adenosine level
adenosine
Prior art date
Application number
SI200431498T
Other languages
Slovenian (sl)
Inventor
Sirpa Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Priority claimed from EP04721913A external-priority patent/EP1608400B1/en
Publication of SI1608400T1 publication Critical patent/SI1608400T1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
SI200431498T 2003-03-28 2004-03-19 Elevation of adenosine level by cytokine-induced expression of cd73 SI1608400T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FI20030467A FI20030467A0 (en) 2003-03-28 2003-03-28 Procedure for treating inflammatory conditions
US51542503P 2003-10-30 2003-10-30
EP04721913A EP1608400B1 (en) 2003-03-28 2004-03-19 Elevation of adenosine level by cytokine-induced expression of cd73
PCT/FI2004/000158 WO2004084933A1 (en) 2003-03-28 2004-03-19 Elevation of adenosine level by cytokine-induced expression of cd73

Publications (1)

Publication Number Publication Date
SI1608400T1 true SI1608400T1 (en) 2010-10-29

Family

ID=8565887

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431498T SI1608400T1 (en) 2003-03-28 2004-03-19 Elevation of adenosine level by cytokine-induced expression of cd73

Country Status (6)

Country Link
JP (1) JP4809762B2 (en)
DK (1) DK1608400T3 (en)
ES (1) ES2346882T3 (en)
FI (1) FI20030467A0 (en)
PT (1) PT1608400E (en)
SI (1) SI1608400T1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015394A1 (en) 2007-03-28 2008-10-02 Henkel Ag & Co. Kgaa Soundproof partition for sealing a cavity
FI20070795A0 (en) * 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy A new biomarker for monitoring disease development and assessing the effectiveness of therapies
JP2021531015A (en) * 2018-07-24 2021-11-18 バイオガイア・エイビーBiogaia AB Treatment with bacterial strains that can increase adenosine levels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510295A (en) * 1999-09-28 2003-03-18 アマリロ バイオサイエンシズ,インコーポレイテッド Low dose IFN gamma for the treatment of disease
DE60129472T2 (en) * 2001-04-03 2008-04-17 U-Cytech B.V. TREATMENT OF HYPOXYA / ISCHAEMIA BLOOD FLOW RESISTANCE WITH BETA-INTERFERON

Also Published As

Publication number Publication date
JP2006522075A (en) 2006-09-28
DK1608400T3 (en) 2010-09-27
FI20030467A0 (en) 2003-03-28
PT1608400E (en) 2010-08-18
ES2346882T3 (en) 2010-10-21
JP4809762B2 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
HK1093581A1 (en) Improved portrayal of navigation objects
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
PT1802579E (en) Derivatives of 3-arylaminopyridine
LT2548880T (en) Compositions for increasing telomerase activity
EP1610784A4 (en) Forms of 5-azacytidine
ZA200606315B (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
GB2424881B (en) Halophenyl derivatives of bisalkylfluorene
IL178384A0 (en) Improved formulations of 6-mercaptopurine
EP1610759A4 (en) Substituted quinobenzoxazine analogs
AU2003206068A8 (en) Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
ZA200705011B (en) Formulations of substituted benzoxazoles
EP1842910A4 (en) Method of enzymatically synthesizing 3'-phosphoadenosine-5'-phosphosulfate
EP1619002A4 (en) Walking structure of object
GB0303843D0 (en) Composition for improving immunity of animals
EP1641595A4 (en) High speed vertical processor
SI1608400T1 (en) Elevation of adenosine level by cytokine-induced expression of cd73
EP1689431A4 (en) Cytoprotective effects of ethyl pyruvate
GB0313630D0 (en) Compositions for the enhanced treatment of depression
ZA200603113B (en) Process for the preparation of risperidone
GB2400427B (en) Improvements relating to the connection of beams
EP1755393A4 (en) Methods of diminishing co-abuse potential
TW562061U (en) Structure of shaping forms
PL369391A1 (en) Method for manufacture of disinfectant as well as the disinfectant
TW553243U (en) Structure of clotheshanger
TW595323U (en) Improved structure of shoe-sole